The global live cell imaging equipment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for live cell imaging in drug discovery and development, increasing number of research and development activities in the field of stem cells, and growing adoption of quantitative phase contrast microscopy.
The global live cell imaging equipment market is segmented on the basis of type into phase contrast microscopy, fluorescent microscopy, and quantitative phase contrast microscopy. Phase contrast microscopy accounted for the largest share in 2018 owing to its wide application across various fields such as developmental biology, drug discovery, and cell biology. Fluorescent microscopy accounted for a significant share due to its wide application across various fields such as developmental biology, drug discovery, and stem cells research. Quantitative phase contrast microscope accounted for a small share due to its limited applications across various fields such as developmental biology or stem cells research.
On the basis of application type into cell biology; developmental biology; drug discovery; stem cells research; other applications (such as cytometry); on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) & Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- The increasing demand for live cell imaging equipment in the pharmaceutical and biotechnology industries is one of the major factors driving the growth of this market.
- The increasing number of research and development activities in the field of life sciences is also driving this market.
- Increasing government funding for research and development activities in life sciences is also fueling this market.
- Increasing awareness about live cell imaging equipment among end users, especially among researchers, will drive this market.
Industry Growth Insights published a new data on “Live Cell Imaging Equipment Market”. The research report is titled “Live Cell Imaging Equipment Market research by Types (Phase Contrast Microscopy, Fluorescent Microscopy, Quantitative Phase Contrast Microscopy, Other), By Applications (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, Others), By Players/Companies Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc.(U.S.)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Live Cell Imaging Equipment Market Research Report
By Type
Phase Contrast Microscopy, Fluorescent Microscopy, Quantitative Phase Contrast Microscopy, Other
By Application
Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, Others
By Companies
Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc.(U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Live Cell Imaging Equipment Market Report Segments:
The global Live Cell Imaging Equipment market is segmented on the basis of:
Types
Phase Contrast Microscopy, Fluorescent Microscopy, Quantitative Phase Contrast Microscopy, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Carl Zeiss AG (Germany)
- Leica Microsystems (Germany)
- Nikon Corporation (Japan)
- Molecular Devices, LCC (U.S.)
- PerkinElmer, Inc. (U.S.)
- GE Healthcare (U.K.)
- Becton, Dickinson and Company (U.S.)
- Olympus Corporation (Japan)
- Sigma Aldrich Corporation (U.S.)
- Thermo Fisher Scientific, Inc.(U.S.)
Highlights of The Live Cell Imaging Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Phase Contrast Microscopy
- Fluorescent Microscopy
- Quantitative Phase Contrast Microscopy
- Other
- By Application:
- Cell Biology
- Stem Cells
- Developmental Biology
- Drug Discovery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Live Cell Imaging Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Live Cell Imaging Equipment is a type of imaging equipment that uses light to capture images of cells in situ. This technology can be used to study the behavior and function of cells in real time, which can help researchers better understand how diseases develop and treatments work.
Some of the key players operating in the live cell imaging equipment market are Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc.(U.S.).
The live cell imaging equipment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Live Cell Imaging Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Live Cell Imaging Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Live Cell Imaging Equipment Market - Supply Chain
4.5. Global Live Cell Imaging Equipment Market Forecast
4.5.1. Live Cell Imaging Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Live Cell Imaging Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Live Cell Imaging Equipment Market Absolute $ Opportunity
5. Global Live Cell Imaging Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Live Cell Imaging Equipment Market Size and Volume Forecast by Type
5.3.1. Phase Contrast Microscopy
5.3.2. Fluorescent Microscopy
5.3.3. Quantitative Phase Contrast Microscopy
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Live Cell Imaging Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Live Cell Imaging Equipment Market Size and Volume Forecast by Application
6.3.1. Cell Biology
6.3.2. Stem Cells
6.3.3. Developmental Biology
6.3.4. Drug Discovery
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Live Cell Imaging Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Live Cell Imaging Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Live Cell Imaging Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Live Cell Imaging Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Live Cell Imaging Equipment Demand Share Forecast, 2019-2029
9. North America Live Cell Imaging Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Live Cell Imaging Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Live Cell Imaging Equipment Market Size and Volume Forecast by Application
9.4.1. Cell Biology
9.4.2. Stem Cells
9.4.3. Developmental Biology
9.4.4. Drug Discovery
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Live Cell Imaging Equipment Market Size and Volume Forecast by Type
9.7.1. Phase Contrast Microscopy
9.7.2. Fluorescent Microscopy
9.7.3. Quantitative Phase Contrast Microscopy
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Live Cell Imaging Equipment Demand Share Forecast, 2019-2029
10. Latin America Live Cell Imaging Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Live Cell Imaging Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Live Cell Imaging Equipment Market Size and Volume Forecast by Application
10.4.1. Cell Biology
10.4.2. Stem Cells
10.4.3. Developmental Biology
10.4.4. Drug Discovery
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Live Cell Imaging Equipment Market Size and Volume Forecast by Type
10.7.1. Phase Contrast Microscopy
10.7.2. Fluorescent Microscopy
10.7.3. Quantitative Phase Contrast Microscopy
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Live Cell Imaging Equipment Demand Share Forecast, 2019-2029
11. Europe Live Cell Imaging Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Live Cell Imaging Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Live Cell Imaging Equipment Market Size and Volume Forecast by Application
11.4.1. Cell Biology
11.4.2. Stem Cells
11.4.3. Developmental Biology
11.4.4. Drug Discovery
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Live Cell Imaging Equipment Market Size and Volume Forecast by Type
11.7.1. Phase Contrast Microscopy
11.7.2. Fluorescent Microscopy
11.7.3. Quantitative Phase Contrast Microscopy
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Live Cell Imaging Equipment Demand Share, 2019-2029
12. Asia Pacific Live Cell Imaging Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Live Cell Imaging Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Live Cell Imaging Equipment Market Size and Volume Forecast by Application
12.4.1. Cell Biology
12.4.2. Stem Cells
12.4.3. Developmental Biology
12.4.4. Drug Discovery
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Live Cell Imaging Equipment Market Size and Volume Forecast by Type
12.7.1. Phase Contrast Microscopy
12.7.2. Fluorescent Microscopy
12.7.3. Quantitative Phase Contrast Microscopy
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Live Cell Imaging Equipment Demand Share, 2019-2029
13. Middle East & Africa Live Cell Imaging Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Live Cell Imaging Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Live Cell Imaging Equipment Market Size and Volume Forecast by Application
13.4.1. Cell Biology
13.4.2. Stem Cells
13.4.3. Developmental Biology
13.4.4. Drug Discovery
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Live Cell Imaging Equipment Market Size and Volume Forecast by Type
13.7.1. Phase Contrast Microscopy
13.7.2. Fluorescent Microscopy
13.7.3. Quantitative Phase Contrast Microscopy
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Live Cell Imaging Equipment Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Live Cell Imaging Equipment Market: Market Share Analysis
14.2. Live Cell Imaging Equipment Distributors and Customers
14.3. Live Cell Imaging Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Carl Zeiss AG (Germany)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Leica Microsystems (Germany)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nikon Corporation (Japan)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Molecular Devices, LCC (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. PerkinElmer, Inc. (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GE Healthcare (U.K.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Becton, Dickinson and Company (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Olympus Corporation (Japan)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sigma Aldrich Corporation (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Thermo Fisher Scientific, Inc.(U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
